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with complaints of pain and swelling of the proximal inter-
phalangeal joints (PIP) of hands and wrist and tibiotarsal jointsntroduction
yme disease (LD) is an infectious disease caused by spiro-
hetes of the genus Borrelia and transmitted by tick bite.
The clinical presentation of LD is divided into three sep-
rated phases: an early localized disease, characterized by
rythema migrans (EM), an early disseminated disease with
otential involvement of the central nervous system and
eart, and a late stage of disease with monoarticular or
ligoarticular arthritis of large joints. During the early phase,
ral antibiotics and, in the case of disseminated disease
ith neurological or cardiac damage, intravenous antibiotics,Please cite this article in press as: de Sá MC, et al. Lyme disease and juven
2016. http://dx.doi.org/10.1016/j.rbre.2015.09.006
re indicated. The arthritis of LD (late stage) should be ini-
ially treated with oral antibiotics for a month; intravenous
 Study conducted at Servic¸o de Pediatria, Centro Hospitalar do Médi
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icenses/by-nc-nd/4.0/).treatment should be limited to patients with severe or persis-
tent disease.
Several studies have suggested a possible inﬂuence of
several infectious agents, including Borrelia, in the etiopatho-
genesis of Juvenile Idiopathic Arthritis (JIA).1
Case  report
A 6-year-old female patient with no relevant past medical
history was referred to Pediatric Rheumatology consultation,ile idiopathic arthritis – a pediatric case report. Rev Bras Reumatol.
o Ave, Vila Nova de Famalicão, Portugal.
bilaterally with several months of development and progres-
sive worsening. There was no fever or history of trauma. She
e under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1 – Proximal interphalangeal joints with inﬂammatory
arthritis observed in a Pediatric Rheumatology consultation.
resided in an urban environment in northern Portugal, but
with regular visits to relatives living in a rural area, where she
had contact with dogs. The family history was irrelevant.
The girl showed multiple circinate erythematous lesions
of 2–5 cm diameter, with a 5-month progression, and was
refractory to oral and topical antifungal treatment. At phys-
ical examination, the patient had signs of inﬂammation and
limitation on active and passive mobilization of all PIP joints of
her hands (Fig. 1) and of the knee, tibiotarsal joints and wrists
bilaterally; and also multiple circinate erythematous lesions
with irregular shapes, scattered on the trunk, upper and lower
limbs and neck (Fig. 2).
Given the clinical picture suggestive of LD, antibiotic
therapy was instituted with oral amoxicillin 1.5 g/day andPlease cite this article in press as: de Sá MC, et al. Lyme disease and juve
2016. http://dx.doi.org/10.1016/j.rbre.2015.09.006
ibuprofen 30 mg/kg/day for 21 days.
The laboratory investigation showed normal complete
blood count (CBC) and general biochemistry (renal function,
Fig. 2 – Multiple circinate erythematous lesions with
irregular shapes, scattered on the trunk and upper limbs. 1 6;x  x x(x x):xxx–xxx
ALT, AST, alkaline phosphatase, thyroid function, ionogram);
erythrocyte sedimentation rate 24 mm/1st hour, C-reactive
protein 1 mg/dL, immunological studies with ANA, ANCA and
rheumatoid factor negative, C3 and C4 slightly increased
(184 mg/dL and 46 mg/dL, respectively), and serology (HIV,
CMV, EBV, toxoplasma, VDRL, Weil-Felix reaction and Wright
reaction) negative. Serological studies for Borrelia burgdorferi
were positive (indirect immunoﬂuorescence, IgG 53.30 AU/mL
[positive, >10 AU/mL]; IgM: 1.37 [positive, >1.09]). In the face
of such results, the diagnosis of EM and arthritis in a con-
text of Lyme disease has been conﬁrmed. The child showed
no changes in her heart and eye examination.
In spite of the treatment, the child related the same com-
plaints of arthralgia, with the appearance of new lesions of
EM. A cycle of 28 days of intravenous ceftriaxone 2 g/day was
then introduced, with complete disappearance of skin lesions.
The resolution of joint symptoms was only temporary;
about two months later, re-aggravation of arthralgia com-
plaints and mobility limitation of wrist and PIP joints occurred.
There was no recurrence of other signs of arthritis and even
of EM.
Taking into account the persistence of the signs and
symptoms of chronic arthritis, anti-inﬂammatory treatment
with oral deﬂazacort (7.5 mg/day) and naproxen (500 mg/day)
and also immunosuppression with oral methotrexate
(14.5 mg/m2/week) were initiated. Then the child presented
a progressive improvement of her pain complaints, but
with persistence of a slight limitation to wrist extension.
Analytically, there were no new changes. Currently, the
patient remains in remission, depending on this therapy; her
behavior and response to therapy are absolutely identical to
what happens with JIA. Worsening of complaints occurred
when a reduction of medication was attempted.
Discussion
LD is predominantly caused by Borrelia burgdorferi and, espe-
cially in Europe, by Borrelia afzelii and Borrelia garinii.  Being
considered as a zoonosis, LD is transmitted by tick bite, com-
monly of Ixodes ricinus.
With signiﬁcant variations among different geographic
areas, the incidence of LD has increased in a sustained man-
ner in the last years.2 In Portugal, the incidence is 0.3 cases per
100,000 inhabitants, close to what happens in other European
countries.3
The early localized disease emerges 7–14 days after
inoculation,4 being characterized by EM and systemic symp-
toms. If left untreated, the erythematous macula at the tick
bite site will develop into a non-itchy, annular, erythema-
tous lesion with larger size (5–70 cm), sometimes showing a
central clearing. If the treatment is not instituted, there fol-
lows the early disseminated disease, characterized by multiple
EM lesions, neurological symptoms (e.g., meningitis or cranial
nerve palsy) and carditis. During the late stage, monoarticular
or oligoarticular arthritis is the most common manifesta-
5nile idiopathic arthritis – a pediatric case report. Rev Bras Reumatol.
tion. First described by Steere et al. in 1977, the association
between LD and joint symptoms has been widely reported.
The joint involvement begins with a large joint, most com-
monly the knee; however, the edema and erythema are more
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bvious than the associated pain. Often, the arthritis is migra-
ory, and if the antibiotic therapy is not started, the complaints
ill persist over several weeks, followed by spontaneous res-
lution. However, the problem may recur in another joint.6
Unusual developments have been described by several
nvestigators, notably the development of joint complaints
oward chronicity in an important proportion of pediatric
atients,7 and the presence of erosive arthropathy in children
nresponsive to antibiotic treatment.8
The presence of EM in an individual who resides or recently
raveled to an endemic area is sufﬁcient for the diagnosis of LD.
n the other hand, in the case of symptoms compatible with
isseminated or late disease, serological conﬁrmation should
e performed prior to the institution of antibiotic therapy.4
The antibiotic of choice in cases of localized disease
s doxycycline, amoxicillin or cefuroxime-axetil orally in a
ourse of 14–21 days. Intravenous antibiotic therapy is indi-
ated in cases of cardiac or neurological manifestation, except
or those isolated cases of facial paralysis. Lyme arthritis can
e treated successfully with oral doxycycline or amoxicillin for
ne month; however, in some cases an intravenous treatment
ay be required.4
The association between JIA and environmental and other
actors such as infection, breastfeeding, immunization, etc.
as already mentioned.9 Thus, it is believed that the pres-
nce of one or more  risk factors, such as a Borrelia infection
n a genetically susceptible individual, may trigger a clinical
icture of JIA.1 However, more  studies are still needed to estab-
ish a relationship between this environmental factor and JIA,
nd also to determine what is the actual pathogenic role of
ifferent environmental risk factors in triggering this disease.
In this case, the child was found with skin lesions sug-
estive of disseminated disease; however, the evolution to
olyarticular arthritis is not characteristic of Lyme arthritis
which typically is of monoarticular or oligoarticular type),
ut her clinical picture is strongly suggestive of polyarticular
IA. The cutaneous manifestations disappeared after treat-
ent, with persistence only of chronic arthritis, which wasPlease cite this article in press as: de Sá MC, et al. Lyme disease and juven
2016. http://dx.doi.org/10.1016/j.rbre.2015.09.006
ontrolled with anti-inﬂammatory agents and methotrexate.
The presented evolution suggests a strong likelihood that
he infection by Borrelia was the triggering event of JIA in this
atient.
9 6;x  x x(x x):xxx–xxx 3
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